TMCnet News
Research and Markets: West Nile Virus Global Clinical Trials Review, Q1, 2011 - Examine Trial Performance, Success Rates & Clinical Trial Status GloballyDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/bddf72/west_nile_virus_gl) has announced the addition of GlobalData's new report "West Nile Virus Global Clinical Trials Review, Q1, 2011" to their offering. The clinical trial report, West Nile Virus Global Clinical Trials Review, Q1, 201 provides data on the West Nile Virus clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on West Nile Virus. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating West Nile Virus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope:
Reasons to Buy:
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/bddf72/west_nile_virus_gl
|

